The Scotts Miracle-Gro (SMG) Earnings Analysis

The Scotts Miracle-Gro (SMG) next reports earnings on 2026-07-29, consensus EPS 2.53 USD. Last quarter (2026-04-29) it beat with EPS 4.53 USD vs 3.97 USD est (+14.1%). It has beaten estimates in 4/4 recent quarters (100%). Trailing P/E 36.16.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does SMG next report earnings?

Next earnings date2026-07-29
Consensus EPS estimate2.53 USD
Revenue estimate1.17B

SMG earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-294.53 USD3.97 USD+14.1%Beat
2026-01-28-0.77 USD-1.04 USD+26%Beat
2025-04-303.98 USD3.92 USD+1.5%Beat
2025-01-29-0.89 USD-1.23 USD+27.6%Beat

Beat rate: 4/4 (100%) over reported quarters with consensus data.

SMG valuation and analyst view

Trailing P/E36.16
Trailing EPS1.909 USD
Price / book-13.93
Dividend yield3.84%
Market cap4.07B
Analyst consensusBuy (9 buy / 7 hold / 1 sell)
Avg price target72.83 USD

Related research pages

Frequently asked questions

When is The Scotts Miracle-Gro (SMG)'s next earnings date?

The Scotts Miracle-Gro is next scheduled to report on 2026-07-29, with a consensus EPS estimate of 2.53 USD and revenue estimate of 1.17B.

Did SMG beat earnings last quarter?

In its 2026-04-29 report, SMG posted EPS of 4.53 USD versus a 3.97 USD estimate — a beat of 14.1%.

What is SMG's earnings track record?

Over the last 4 reported quarters with consensus data, SMG beat estimates 4 times (100%).

What is SMG's current P/E ratio and EPS?

SMG trades at a trailing P/E of 36.16 on trailing EPS of 1.9087779690189328 USD.

What do analysts rate SMG?

Analyst consensus is "Buy" across 17 ratings (0 strong buy, 9 buy, 7 hold, 1 sell, 0 strong sell). Average 12-month price target: 72.83 USD.